Results 51 to 60 of about 7,943 (176)
Abstract Purpose Previous research demonstrates that body image concerns are highly prevalent in stoma patients and can significantly limit quality of life, yet the psychological processes underlying these changes remain under‐theorized in the literature.
Siân Levell +2 more
wiley +1 more source
Abstract Aim This study aimed to examine disease‐specific quality of life (QoL) among individuals with diverticulosis across different clinical manifestations and identify characteristics associated with an unacceptable symptom burden. Method This was a population‐based study within the DIVIPACT cohort, linking cross‐sectional questionnaire data ...
Helene R. Dalby +2 more
wiley +1 more source
Increased accuracy in diagnosing diverticulitis using predictive clinical factors
Background: The aim of this study was to identify clinical factors leading to increased diagnostic accuracy for acute colonic diverticulitis. Methods: Patients with clinical suspicion of acute colonic diverticulitis verified with computed tomography (CT)
Johanna Sigurdardottir +3 more
doaj +1 more source
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern +14 more
wiley +1 more source
Evaluating the Efficacy of Cytokine‐Directed Therapies in the Management of VEXAS Syndrome
Objective To evaluate the efficacy of cytokine‐directed therapies in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory somatic) syndrome using previously proposed treatment response criteria. Methods All patients with genetically confirmed VEXAS syndrome who received targeted therapies with JAK inhibitors (JAKi), tumor necrosis factor α inhibitors
Daniel Montes +15 more
wiley +1 more source
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonists have transformed the management of type 2 diabetes and obesity. Gastrointestinal (GI) adverse events are the most common limitation of these therapies and a leading cause of discontinuation ...
Vikash Singhani +6 more
wiley +1 more source
Background/Aims: Currently, right colonic uncomplicated diverticulitis is typically treated with antibiotic therapy. However, the optimal duration of treatment is unknown. The aim of the present study was to compare the treatment failure rates between 1-
Jung Ho Park +2 more
doaj +1 more source
ABSTRACT Background Restorative colorectal surgery after emergency stoma formation is challenging because of adhesions, altered anatomy, and pelvic dissection. We evaluated the technical feasibility of stoma‐site single‐port robotics restorative colorectal surgery using the da Vinci SP system.
Hyeon Sik Jeong +3 more
wiley +1 more source
Background/Aims: Besides age, risk factors for colonic diverticular disease include dietary meat intake and Western lifestyles, which are also risk factors for obesity.
Sang Pyo Lee +3 more
doaj +1 more source
Virtual Care of Acute Diverticulitis: A Phase I/II Randomised Clinical Feasibility Trial
Virtual care for acute uncomplicated diverticulitis appears feasible, safe and acceptable, with potential advantages over inpatient care, including superior patient‐reported experience. ABSTRACT Background Acute uncomplicated diverticulitis is commonly managed in hospital in Australia.
Phillip F. Yang +10 more
wiley +1 more source

